Open AccessPatterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study
Author(s) -
Douglas S. Fuller,
Bruce M. Robinson,
Francesco Locatelli,
Ronald L. Pisoni
Publication year - 2018
Publication title -
the nephron journals/nephron journals
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.951
H-Index - 72
eISSN - 2235-3186
pISSN - 1660-8151
DOI - 10.1159/000490202
Subject(s) - medicine , darbepoetin alfa , medical prescription , epoetin alfa , hemodialysis , erythropoietin , anemia , dialysis , pharmacology
Clinicians providing dialysis care have numerous erythropoiesis-stimulating agents (ESAs) available for treating anemia. We sought to provide a contemporary description of ESA types used in hemodialysis (HD) settings in nine European countries.